Friday, July 10, 2026

Drug profile · INN

resminostat

resminostat (KINSELBY) is an FDA-listed pharmaceutical active ingredient.

EMA: unknown Antineoplastic and immunomodulating agents (L01) L01X
Patents linked 1
Pipeline programs 0
News articles 0
Drug details — resminostat
Class
Antineoplastic and immunomodulating agents (L01)
Route
Patents
1
Programs
0
Data quality
0.83

Quick answer

resminostat (KINSELBY) is an FDA-listed pharmaceutical active ingredient.

Key facts

INN resminostat
Brand KINSELBY
Therapeutic class Antineoplastic and immunomodulating agents (L01)
ATC code L01X

Approval history

Authority Status Date
EMA unknown

Related & competitor drugs

  1. abiraterone acetate Antineoplastic and immunomodulating agents (L02)
  2. anagrelide Antineoplastic and immunomodulating agents (L01)
  3. apremilast Antineoplastic and immunomodulating agents (L04)
  4. arsenic trioxide Antineoplastic and immunomodulating agents (L01)
  5. axitinib Antineoplastic and immunomodulating agents (L01)
  6. azacitidine Antineoplastic and immunomodulating agents (L01)

Related patents

  1. WO 2017178577

    APPLICATION MÉDICALE DE RESMINOSTAT CHEZ DES PATIENTS ASIATIQUES

    Expires Wed Oct 14 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is resminostat?

resminostat (KINSELBY) is an FDA-listed pharmaceutical active ingredient.

What is the brand name for resminostat?

KINSELBY is a marketed brand name for resminostat. Check FDA Drugs@FDA for the current US label holder and prescribing information.